Stockreport

Trevi Therapeutics Inc (TRVI) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF This article first appeared on GuruFocus Cash and Cash Equivalents: Approximately $188 million at the end of 2025. Cash Runway: Expected to extend into 2028. Rele [Read more]